We are at the forefront of pioneering research into heart and lung disease; successful research trials can lead to the development of new drugs, treatments and procedures, all aimed at helping improve the lives of patients in the UK and beyond.
Sharing what we do is an important part of the work we do and we offer even more insight into our research through our podcasts and videos which cover a range of topics related to heart and lung research. Click on the links below to watch and listen:
Many of our clinicians are at the forefront of caring for patients with COVID-19 as well as collaborating on national and international clinical trials.
To help share best clinical practice and help global efforts to tackle the virus, our clinicians have featured in webinars produced by Optima Education and Rutherford Medicine in collaboration with Dr Jonathan Hill.
Dr Anand Shah discusses his research into lung infections, in particular cystic fibrosis and bronchiectasis, and how finding alternatives for anti-fungal medication is just as important as finding alternatives for antibiotics.
Dr Sanjay Prasad discusses dilated cardiomyopathy and explores his research into DCM which causes the walls of the heart to become too stretched and thin to pump blood effectively across the body.
Dr John Wort talks more about his research into this disease, the condition itself and how our hospitals lead the way in pulmonary hypertension treatment.
Dr Toby Maher talks about his research into idiopathic pulmonary fibrosis (IPF), a condition which causes progressive scarring of the lungs. It explores recent research into home monitoring for IPF and how it might help with research trials in the future.
Dr Tina Khan talks about her PhD research into refractory angina - a serious type of angina resistant to treatment with medication or revascularisation with stents and/or surgery.
This short animation shows how research has always been the key to discovering new and innovative treatments that improve patient care and help to prevent and cure disease.